People's Assembly

Connecting people with their representatives

  • About us
    • Who we are
    • Source Data
    • For Representatives
  • Contact us
  • Facebook
  • Twitter
  • Instagram
  • menu
  • search
  • Home
  • Rep Locator
  • People
    • Find by name
    • Parliament
      • National Assembly
      • National Council of Provinces
    • Provinces
      • Eastern Cape
      • Free State
      • Gauteng
      • KwaZulu-Natal
      • Limpopo
      • Mpumalanga
      • Northern Cape
      • North West
      • Western Cape
  • Blog
  • MP Profiles
  • MP Attendance
  • Public Participation
    • Make yourself heard
    • Elections
      • Election 2014 Candidates
      • Election 2019 Candidates
    • Petitions
    • Write to a Committee
  • Hot Topics
    • Questions
    • MP Assets
    • MP Corner
    • Infographics
  • Home »
  • Hansard »
  • 2014 »
  • March »
  • 13 »
  • PROCEEDINGS OF THE NATIONAL ASSEMBLY (Thursday, 13 March 2014)

FISHERIES ON THE OVERSIGHT VISIT TO THE AGRICULTURAL RESEARCH COUNCIL (ARC) AND THE ONDERSTEPOORT BIOLOGICAL PRODUCTS (OBP) IN PRETORIA, GAUTENG PROVINCE, DATED 11 MARCH 2014.

  • ← 10. REPORT OF THE PORTFOLIO COMMITTEE ON AGRICULTURE, FORESTRY AND
  • 1. ENGAGEMENT DURING OVERSIGHT VISIT →
  • (narrative) 13 Mar 2014 hansard
    The Portfolio Committee on Agriculture, Forestry and Fisheries, having undertaken an oversight visit to the ARC and OBP in the Gauteng Province from 4 to 5 February 2014, reports as follows: 1. Background
    Link in context Link
  • (narrative) hansard
    The Agricultural Research Council (hereinafter referred to as ARC) and the Onderstepoort Biological Products (hereinafter referred to as OBP) are public entities that reports directly to the Department of Agriculture, Forestry and Fisheries (hereinafter referred to as the Department). The ARC was established in terms of Section 2 of the Agricultural Research Act, 1990 (Act No. 86 of 1990). It is the principal agricultural research institution in the county that provides agricultural research and technology development to support the agricultural community. The OBP was established in terms of the Onderstepoort Biological Products Incorporation Act, 1999 (Act No. 19 of 1999) and its mandate is to manufacture veterinary vaccines and related products to prevent and control animal diseases that impact on food security, human health and livelihoods.
    Link in context Link
  • (narrative) hansard
    For the past two financial years, i.e. 2011/12 and 2012/13 the Portfolio Committee observed that there was little collaboration between the ARC and OBP on research activities on livestock diseases and vaccine improvement; and the Committee was particularly concerned with outbreaks of diseases of economic importance that sometimes lead to the banning of South African products in some export markets, e.g. foot-and-mouth disease, avian influenza, citrus black spot, etc. The Committee also observed that both entities, the OBP being a national key point, were also not getting sufficient Government funding to address challenges associated with outbreaks of diseases. Based on these observations, the Portfolio Committee recommended that the Department ensures that there is collaboration between the ARC and OBP on livestock disease-related programmes; and to consider increasing funding for the ARC and OBP, particularly for the refurbishment of research facilities and aged infrastructure.
    Link in context Link
  • (narrative) hansard
    1. Objective of the Visit
    Link in context Link
  • (narrative) hansard
    Part of the oversight responsibilities of the Portfolio Committee on Agriculture, Forestry and Fisheries over the work of the Department and its entities is to examine the Strategic Plans and associated Annual Performance Plans (APPs), as well as budgets of the Department and its six entities. In the 2010/11 financial year, additional funding was allocated to the ARC for the establishment of a state of the art foot-and-mouth disease (FMD) Facility for research on, and the manufacturing of, FMD vaccines. In 2012/13, the OBP received funding from National Treasury for upgrading and modernising the vaccine manufacturing facilities. The Committee took a resolution to undertake an oversight visit to the ARC and OBP to oversee progress in the establishment of the FMD Facility at the ARC, the vaccine manufacturing facilities at OBP and further progress regarding other Committee recommendations as outlined in the Committee's 2011/12 and 2012/13 Budget Review and Recommendation Reports (BRRRs). 2. Delegation
    Link in context Link
  • (narrative) hansard
    The delegation of the Committee composed of Mr M Johnson, ANC (Chairperson and Leader of the delegation); Ms NM Twala, ANC; Ms RE Nyalungu, ANC, Ms ME Pilusa-Mosoane, ANC and Ms A Steyn, DA. The delegation was supported by Ms A Kakaza, Committee Secretary; Ms N Mgxashe, Content Advisor, Ms N Qwabe, Committee Researcher (Agriculture and Forestry) and Ms N Diya, Committee Assistant.
    Link in context Link
  • ← 10. REPORT OF THE PORTFOLIO COMMITTEE ON AGRICULTURE, FORESTRY AND
  • 1. ENGAGEMENT DURING OVERSIGHT VISIT →

Correct this page

Follow us

  • Facebook
  • Twitter
  • Instagram

Sitemap

  • Home
  • Rep Locator
  • People
    • Find by name
    • Parliament
      • National Assembly
      • National Council of Provinces
    • Provinces
      • Eastern Cape
      • Free State
      • Gauteng
      • KwaZulu-Natal
      • Limpopo
      • Mpumalanga
      • Northern Cape
      • North West
      • Western Cape
  • Blog
  • MP Profiles
  • MP Attendance
  • Public Participation
    • Make yourself heard
    • Elections
      • Election 2014 Candidates
      • Election 2019 Candidates
    • Petitions
    • Write to a Committee
  • Hot Topics
    • Questions
    • MP Assets
    • MP Corner
    • Infographics
  • Links
  • Get the data

Contact us

People's Assembly
contact@pa.org.za

Tel: (021) 465 8885

Fax: (021) 465 8887

2nd Floor 9 Church Square Parliament Street
Cape Town 8001
South Africa

Disclaimer

The data for this site has been sourced form a range of organisations and websites and often received in formats that are hard to process. As a result, errors can occur - if you see something that you think is an error, please click on the "Correct This Page" button and let us know so that we can investigate. Please click here to read more about our source data.

  • Privacy
  • Give us feedback

This site runs on open source code written by mySociety.